openPR Logo
Press release

Cutaneous Fibrosis Treatment Market Growth Factors, Opportunities, Ongoing Trends and Key Players 2032

11-23-2022 08:59 AM CET | Health & Medicine

Press release from: Persistence Market Research

One of the essential elements predicted to drive the cutaneous fibrosis treatment market over the coming years is the rising incidence of cutaneous fibrosis conditions such as systemic sclerosis and keloids, which has led to an increase in clinical trials for developing new therapies for treatment. The global cutaneous fibrosis therapy market was worth US$ 574.4 Mn in 2021 and it is expected to increase at a CAGR of 6.8% over the forecast period (2022-2032).

Request For Free Sample Report of "Cutaneous Fibrosis Treatment Market"@ https://www.persistencemarketresearch.com/samples/33114

Although illnesses such as keloid, scleroderma, radiation-induced skin fibrosis, and chronic graft-versus-host disease-associated (GVHD) are common, there is less knowledge regarding the therapeutic options for cutaneous fibrosis associated with these diseases. Various firms and healthcare professionals are putting forth a lot of effort to address this low level of awareness.

According to the U.S. CDC, almost 75,000 people in the country suffer from systemic scleroderma.

Several environmental factors play a key role in the occurrence of systemic scleroderma, with the European region projecting high prevalence rates, following the U.S. Greater awareness of the disease and associated indications assist with augmenting diagnosis rates, which is then followed by enhanced treatment-seeking rates.

For the treatment of cutaneous fibrosis, several pharmaceutical companies are testing an array of pharmacological compounds, including biologics. A few key players are already testing pharmacological compounds for the treatment of cutaneous fibrosis, while others are waiting for regulatory authorizations to begin with the clinical assessments of their products.

Competitive Landscape

Manufacturers and key competitors in the cutaneous fibrosis treatment market employ a variety of key promotional strategies. Acquisition is a widely-used primary marketing approach, as it allows companies to assist patients with their specific disease indications by expediting innovation and driving productivity.

Novartis and Galapagos and MorphoSys signed an exclusive license agreement in July 2018 for MOR106, an experimental biologic drug that is a new antibody aimed against IL-17C.
In March 2022, Pfizer Inc. signed an agreement for the acquisition of Arena Pharmaceuticals, a company that develops innovative potential therapies for the treatment of immune-inflammatory diseases.
In March 2019, the European Commission approved Roche's "MabThera" (rituximab) for a rare autoimmune disease.
In October 2021, Amgen completed its acquisition of Teneobio, Inc. This acquisition helped in advancing R&D activities to develop highly innovative products for patients.

Buy Full Report Now and Get Up to 20% Discount @ https://www.persistencemarketresearch.com/checkout/33114

Key Takeaways

By drug class, immunotherapy drugs are expected to hold 45.6% market value share by the end of 2032.
Oral route of administration is leading with 68.2% market share in 2021.
Scleroderma dominated the market by indication with a share of around 63.4% in 2021.
By distribution channel, retail pharmacies are expected to be the most lucrative segment with a value share expected to reach 47% by 2032.
North America is set to be the leading region with a projected value share of 37.4% by 2032.

"Rising prevalence of skin diseases and increasing awareness regarding cutaneous fibrosis treatments are set to propel the growth of the global cutaneous fibrosis treatment market," says an analyst of Persistence Market Research.

 Key Questions Answered in This Report.

What are the Roadblocks for Cutaneous Fibrosis Treatment Suppliers?
What are the Key Opportunities for Cutaneous Fibrosis Treatment Manufacturers?
How is Focus on Safety Influencing Cutaneous Fibrosis Treatment Demand?
What is the Regulatory Impact on Global Sales of Cutaneous Fibrosis Treatment?
Which Region Offers the Largest Opportunity for Sales of Cutaneous Fibrosis Treatment?
Where Does the U.S. Stand in the Market for Cutaneous Fibrosis Treatment?
What Is the Outlook for Cutaneous Fibrosis Treatment Manufacturers in China?
Why is Germany a Lucrative Market for Cutaneous Fibrosis Treatment Manufacturers?
Why Will Belgium Outpace Other European Markets for Cutaneous Fibrosis Treatment?
Why is There High Demand for Tires in Cutaneous Fibrosis Treatment?
Why are Sales of Cutaneous Fibrosis Treatment Surging?

Request Customization @ https://www.persistencemarketresearch.com/request-customization/33114

Media Contact:
Persistence Market Research
305 Broadway,7th Floor New York City, NY 10007 United States
Call +1-646-568-7751
Call +1 800-961-0353
sales@persistencemarketresearch.com

About Us

Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cutaneous Fibrosis Treatment Market Growth Factors, Opportunities, Ongoing Trends and Key Players 2032 here

News-ID: 2817765 • Views:

More Releases from Persistence Market Research

North America Wiring Devices Market Projected to Reach USD 26.46 Billion by 2031
North America Wiring Devices Market Projected to Reach USD 26.46 Billion by 2031
Overview of the North America Wiring Devices Market The North America wiring devices market is poised for steady growth over the forecast period, with its size estimated at US$ 18.96 billion in 2024, projected to reach US$ 26.46 billion by 2031, reflecting a CAGR of 4.9%. The market is witnessing substantial expansion due to increasing urbanization, a rising number of residential and commercial construction projects, and the adoption of energy-efficient and
Global Forged Automotive Components Market Poised for Steady Growth, Projected to Reach US$ 70.7 Billion by 2032
Global Forged Automotive Components Market Poised for Steady Growth, Projected t …
The global forged automotive components market is on a robust growth trajectory, currently valued at approximately US$ 50.3 billion in 2025 and forecasted to expand to US$ 70.7 billion by the end of 2032. This growth represents a compound annual growth rate (CAGR) of 5.0% over the coming decade, driven by increasing automotive production, technological advancements, and evolving consumer preferences toward durable, high-performance vehicle parts. Forged automotive components are critical to
Global Electric Cargo Bike Market Set to Accelerate at 11.9% CAGR, Reaching US$ 2.14 Billion by 2032, Reports Persistence Market Research
Global Electric Cargo Bike Market Set to Accelerate at 11.9% CAGR, Reaching US$ …
The global electric cargo bike market is set to experience substantial growth over the coming decade, with Persistence Market Research (PMR) forecasting a compound annual growth rate (CAGR) of 11.9% from 2023 through 2032. Valued at approximately US$ 800 million in 2021, the market is expected to surge to a projected valuation of US$ 2.14 billion by the end of 2032. Notably, electric cargo bikes accounted for 66.2% of the
Bicycle Bearings Market Set for Steady Growth with 6.5% CAGR Through 2032, Driven by Urbanization and Demographic Trends
Bicycle Bearings Market Set for Steady Growth with 6.5% CAGR Through 2032, Drive …
The global bicycle bearings market is poised for significant expansion over the forecast period of 2025 to 2032, according to the latest report released by Persistence Market Research. Valued at approximately US$ 5.99 billion in 2024, the market is projected to reach US$ 6.35 billion by 2025 and further escalate to nearly US$ 9.86 billion by 2032. This growth trajectory reflects a compound annual growth rate (CAGR) of 6.5%, underscoring

All 5 Releases


More Releases for Cutaneous

Cutaneous Lupus Erythematosus (CLE) Market
Introduction Cutaneous Lupus Erythematosus (CLE) is a chronic autoimmune skin disorder, often associated with systemic lupus erythematosus (SLE), that presents as inflammation, rashes, and photosensitivity. While CLE is rarely fatal, it significantly affects patients' physical and emotional well-being, often leading to scarring, disfigurement, and social stigma. Over the past decade, the market for CLE therapies has gained global importance as research into autoimmunity has accelerated and biologic therapies have transformed dermatology. Rising
Cutaneous Angiosarcoma Market New Product Development & Latest Trends
Introduction Cutaneous angiosarcoma is a rare and aggressive malignancy that originates from endothelial cells lining blood vessels and lymphatics in the skin. Though it represents a small fraction of soft-tissue sarcomas, its high recurrence rates, metastatic potential, and poor prognosis make it one of the most challenging cancers to manage. The condition most frequently affects elderly patients and is often associated with chronic lymphedema, prior radiation exposure, or immunosuppression. Traditional management has
Emerging Trends Influencing The Growth Of The Cutaneous T-Cell Lymphoma Market: …
We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries. How Big Is the Cutaneous T-Cell Lymphoma Market Size Expected to Be by 2034? The market for cutaneous T-cell lymphoma has witnessed substantial growth in the past few years. It is projected to rise from a size of $2.54 billion in 2024 to $2.72 billion in 2025, equating to a compound annual
Prominent Cutaneous Lupus Erythematosus Market Trend for 2025: Advancements In C …
What combination of drivers is leading to accelerated growth in the cutaneous lupus erythematosus market? The rising prevalence of skin infections is expected to drive the growth of the cutaneous lupus erythematosus (CLE) market. Skin infections are caused by microorganisms that invade the skin, triggering immune responses that can worsen symptoms in individuals with CLE. For example, the UK saw a 33.7% increase in MRSA cases caused by skin and soft
Key Trend Reshaping the Cutaneous Lupus Erythematosus Market in 2025: Advancemen …
What Are the Projections for the Size and Growth Rate of the Cutaneous Lupus Erythematosus Market? The market size for cutaneous lupus erythematosus has seen quick expansion in the past few years. The growth is estimated to move from $2.24 billion in 2024 to $2.51 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 12.0%. This considerable increase in the historic period is a result of factors such as
Cutaneous Lupus Erythematosus Market Trends & Analysis Report 2024
"The Business Research Company recently released a comprehensive report on the Global Cutaneous Lupus Erythematosus Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. Ready to Dive into Something Exciting? Get Your Free Exclusive